Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
4DX.AX
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q2.20
N/A
-0.06
vs -0.03
Q4.20
N/A
-0.05
vs -0.02
Q2.21
N/A
-0.03
vs -0.06
Q4.21
N/A
-0.04
vs -0.05
Q2.22
N/A
-0.04
vs -0.03
Q4.22
N/A
-0.05
vs -0.04
Q2.23
N/A
-0.05
vs -0.04
Q4.23
N/A
-0.04
vs -0.05
Q2.24
N/A
-0.05
vs -0.05
Q4.24
N/A
-0.03
vs -0.04
Sales Growth
YoY
Current
Estimates
Q2.20
-81%
132.5K vs 694.4K
Q4.20
-86%
150.7K vs 1.1M
Q2.21
-50%
66.3K vs 132.5K
Q4.21
+4%
156.6K vs 150.7K
Q2.22
+1255%
897.7K vs 66.3K
Q4.22
-68%
49.5K vs 156.6K
Q2.23
-74%
232.7K vs 897.7K
Q4.23
+1502%
792.5K vs 49.5K
Q2.24
+1173%
3M vs 232.7K
Q4.24
+265%
2.9M vs 792.5K
Return on Equity
QoQ
Q2.21
-10%
-0.10
vs -0.28
Q4.21
-18%
-0.18
vs -0.10
Q2.22
-20%
-0.20
vs -0.18
Q4.22
-37%
-0.37
vs -0.20
Q2.23
-21%
-0.21
vs -0.37
Q4.23
-17%
-0.17
vs -0.21
Q2.24
-29%
-0.29
vs -0.17
Q4.24
-32%
-0.32
vs -0.29
Institutionnal Ownership
Relative Strength
4DX.AX
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
138%2025-Revenue
-145%2025-EPS
69%2025-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Quote Panel
Key Metrics
4DMedical Limited operates as a medical technology company in Australia and the United States. It commercializes XV Technology, a four-dimensional lung imaging technology. The company also offers software as a service delivery model; XV lung ventilation analysis software; Permetium, a preclinical imaging system which quantify regional changes in pulmonary function; and AccuVent 200, a small animal ventilator. The company was incorporated in 2012 and is based in Carlton, Australia.
ASX
Unprofitable
EPS improving
Unprofitable
EPS improving
Relative Strenght
Volume Buzz
-39%
Earning Acce
No
Dist 52w H.
66%Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How 4DX.AX compares to sector?